13G Filing: Park West Asset Management and PLx Pharma Inc. (PLXP)

* Beneficial ownership percentage is based
upon 8,683,915 shares of Common Stock issued and outstanding immediately after the consummation of the Company’s public offering
of Common Stock, as reported by the Company in its prospectus supplement dated June 9, 2017 (File No. 333-204830), filed with the
Securities and Exchange Commission on June 12, 2017.   PWAM is the investment manager to the PW Funds, and Mr. Park is
the sole member and manager of PWAM.  As of June 9, 2017, PWIMF held 953,465 shares of Common Stock and, subject to the
limitation described below, warrants to purchase up to 902,528 shares of Common Stock and PWPI held 122,258 shares of Common Stock
and, subject to the limitation described below, warrants to purchase up to 115,653 shares of Common Stock.  The warrants are not exercisable
until December 15, 2017, expire on June 14, 2027, and contain a provision prohibiting exercise to the extent that the holder,
together with its affiliates, would beneficially own in excess of 9.99% of the number of shares of Common Stock outstanding immediately
after giving effect to such exercise (subject to decrease upon prior written notice to the Company). As a result of the foregoing, for purposes of Reg. Section
240.13d-3, the Reporting Persons may be deemed to beneficially own the 1,075,723 shares of Common Stock held in the aggregate by
the PW Funds, and no shares of Common Stock underlying the warrants held in the aggregate by the PW Funds, for an aggregate beneficial
ownership percentage of approximately 12.4% of the shares of Common Stock deemed issued and outstanding as of June 9, 2017.